Lv5
1390 积分 2022-08-16 加入
Using Oncolytic Virus to Retask CD19-Chimeric Antigen Receptor T Cells for Treatment of Pancreatic Cancer: Toward a Universal Chimeric Antigen Receptor T-Cell Strategy for Solid Tumor
1个月前
已完结
Progress and challenges in glypican-3 targeting for hepatocellular carcinoma therapy
1个月前
已完结
Interleukin-1 receptor accessory protein (IL-1RAP): A magic bullet candidate for immunotherapy of human malignancies
1个月前
已完结
Autologous stem cell boost improves persistent immune effector cell associated hematotoxicity following BCMA directed chimeric antigen receptor T (CAR T) cell therapy in multiple myeloma
1个月前
已完结
Efficacy and toxicity for CD22/CD19 chimeric antigen receptor T-cell therapy in patients with relapsed/refractory aggressive B-cell lymphoma involving the gastrointestinal tract
2个月前
已完结
A Comprehensive and Robust Analytical Platform for Clinical Grade CAR-T Cells
2个月前
已关闭
Anti-CD19 CAR T cells for pediatric patients with treatment-refractory autoimmune diseases
3个月前
已完结
Treatment of Cerebral Edema
3个月前
已完结
290 A translatable in vivo CAR-T platform enabled by CLAMP technology for targeted mRNA delivery to T cells
3个月前
已完结
皖公网安备34019202002308
